Camp4 Therapeutics Corp
CAMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001736730
In the last 90 days, Camp4 Therapeutics Corp insiders filed 5 open-market purchases and 4 sales; 61 institutions reported holding it in 13F filings for Q2 2026, worth $182.2M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Camp4 Therapeutics Corp changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 29 | 29 | 0 |
| Shares | 11.7M | 28.2M | +16.5M (+140.2%) |
| Value | $17.0M | $84.6M | +$67.6M (+396.9%) |
New holders (8)
Institutions that held Camp4 Therapeutics Corp at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Janus Henderson Group PLC | 4,640,970 | $13.9M | 0.01% |
| Vivo Capital, LLC | 3,921,568 | $11.8M | 0.95% |
| Adage Capital Partners GP, L.L.C. | 1,960,784 | $5.88M | 0.01% |
| Silverarc Capital Management, LLC | 653,594 | $1.96M | 0.28% |
| Two Sigma Investments, LP | 97,371 | $292.1K | 0.00% |
| State Street Corp | 26,000 | $78.0K | 0.00% |
| Mariner, LLC | 17,298 | $51.9K | 0.00% |
| Barclays PLC | 70 | $210 | 0.00% |
Sold out (8)
Institutions that held Camp4 Therapeutics Corp at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Goldman Sachs Group Inc | 26,511 | $38.4K |
| Qube Research & Technologies Ltd | 14,871 | $21.6K |
| Verition Fund Management LLC | 14,760 | $21.4K |
| Cantor Fitzgerald, L. P. | 12,320 | $17.9K |
| JPMorgan Chase & Co | 238 | $345 |
| Wells Fargo & Company | 119 | $173 |
| Nisa Investment Advisors, LLC | 101 | $146 |
| EverSource Wealth Advisors, LLC | 3 | $4 |